Sickle Cell Disease Therapies: ASH and FDA Unveil New Recommendations to Guide Clinical Development #ASH19

da Salute H24 — 9 dicembre 2019 alle 8:21

The American Society of Hematology (ASH) released the most comprehensive set of recommendations to date aimed at establishing uniformity and global standards for clinical trial endpoints used to evaluate new therapies for sickle cell disease (SCD). Continua »


Scrivi un commento